Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01328704 · ClinicalTrials.gov registry record
Evaluate the Change in Iron, Vitamin D, and C-Reactive Protein Level (CRP) in a 12 to 24 Week Period
A clinical trial of Anemia and Vitamin D Deficiency, sponsored by Avera McKennan Hospital & University Health Center.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT01328704 is a study of Anemia and Vitamin D Deficiency that has completed, run by Avera McKennan Hospital & University Health Center. The registered enrollment target is 50 participants, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01328704, a study of Anemia and Vitamin D Deficiency, has completed, sponsored by Avera McKennan Hospital & University Health Center.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to observe changes in iron status and vitamin D status during a 12-24 week supervised training program, specifically males and females between the ages of 30 and 50 years old.
Conditions Studied
Study Locations (1)
South Dakota
- Avera Sports Institute - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01328704
The ClinicalTrials.gov registry entry for NCT01328704 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (88% lower). The listed sponsor is Avera McKennan Hospital & University Health Center, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Anemia appearing as the primary indexed condition, and to 0 interventions.
NCT01328704 reports 1 study location spanning 1 distinct geographic area - top geographies include South Dakota.
Frequently Asked Questions
What is clinical trial NCT01328704 about?
NCT01328704 is a clinical study titled "Evaluate the Change in Iron, Vitamin D, and C-Reactive Protein Level (CRP) in a 12 to 24 Week Period". The purpose of this study is to observe changes in iron status and vitamin D status during a 12-24 week supervised training program, specifically males and females between the ages of 30 and 50 years old.
What is the current status of trial NCT01328704?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2012-01. Estimated completion is 2013-03.
What conditions does trial NCT01328704 study?
This clinical trial studies the following conditions: Anemia, Vitamin D Deficiency.
Who is sponsoring clinical trial NCT01328704?
This trial is sponsored by Avera McKennan Hospital & University Health Center, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01328704 being conducted?
This trial has 1 study location across South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
RECRUITING · Phase 2
-
Study of DISC-0974-201 in Participants With IBD and Anemia
RECRUITING · Phase 2
-
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RECRUITING · Phase 1
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RECRUITING · Phase 3
-
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.